Corticotropin Patent Expiration

Corticotropin is used for promoting new vessel formation in ophthalmic diseases. It was first introduced by Sanofi Aventis Us Llc in its drug Acthar on Approved Prior to Jan 1, 1982. Other drugs containing Corticotropin are Corticotropin, Purified Cortrophin Gel, Acthar Gel, Acthar Gel (Autoinjector), Acth. 6 different companies have introduced drugs containing Corticotropin.

Corticotropin Patents

Given below is the list of patents protecting Corticotropin, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Purified Cortrophin Gel	US11975047	Methods for storing and warming purified corticotropin compositions	Oct 27, 2043	Ani Pharms
Purified Cortrophin Gel	US12102662	Methods for storing and warming purified corticotropin compositions	Oct 27, 2043	Ani Pharms
Purified Cortrophin Gel	US12233105	Methods for storing and warming purified corticotropin compositions	Oct 27, 2043	Ani Pharms
Purified Cortrophin Gel	US12324787	Contactless optical process for identifying objects	Oct 27, 2043	Ani Pharms
Acthar Gel	US11752199	Methods of modulating pericytes	Jul 18, 2041	Mallinckrodt Ireland
Acthar Gel (autoinjector)	US11752199	Methods of modulating pericytes	Jul 18, 2041	Mallinckrodt Ireland

Corticotropin is used in a drug marketed by 1 company: Bimeda Animal Health Limited

Other drugs containing Corticotropin are: Acth gel ,

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List